Association of Circulating Metabolites With Disease Severity and Mortality in Patients With Idiopathic Pulmonary Fibrosis: Data From the IPF-PRO Registry

被引：0
|
作者：
Summer, R. S. [1 ]
Todd, J. L. [2 ,3 ]
Neely, M. L. [2 ,3 ]
Lobo, L. [4 ]
Namen, A. M. [5 ]
Newby, L. [2 ,3 ]
Shafazand, S. [6 ,7 ]
Suliman, S.
Hesslinger, C. [8 ]
Keller, S. [8 ]
Leonard, T. B. [9 ]
Palmer, S. M. [2 ,3 ]
Ilkayeva, O. [10 ]
Muehlbauer, M. J. [10 ]
Newgard, C. B. [10 ]
Roman, J. [11 ]
机构：
[1] Thomas Jefferson Univ, Philadelphia, PA USA
[2] Duke Clin Res Inst, Durham, NC USA
[3] Duke Univ, Med Ctr, Durham, NC USA
[4] UNC, Sch Med, Chapel Hill, NC USA
[5] Wake Forest Sch Med, Winston Salem, NC USA
[6] Univ Miami, Miami, FL USA
[7] Univ Louisville, Louisville, KY USA
[8] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
[9] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA
[10] Duke Mol Physiol Inst, Durham, NC USA
[11] Jane & Leonard Korman Inst, Philadelphia, PA USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6534
引用
收藏
页数：2
相关论文
共 50 条
  • [31] CHARACTERISTICS OF LONG-TERM SURVIVORS WITH IDIOPATHIC PULMONARY FIBROSIS: DATA FROM THE IPF-PRO REGISTRY
    Kim, Hyun
    Bender, Shaun
    Patel, Nina
    Neely, Megan
    Conoscenti, Craig
    Leonard, Thomas
    Palmer, Scott
    CHEST, 2021, 160 (04) : 1251A - 1251A
  • [32] Associations Between Circulating Matrix Metalloproteinases and Their Inhibitors and Mortality in Patients with IPF: Data from the IPF-PRO Registry
    Tood, J. L.
    Neely, M. L.
    Overton, R.
    Kaner, R. J.
    Lasky, J. A.
    Namen, A.
    Porteous, M.
    Hesslinger, C.
    Leonard, T. B.
    Palmer, S. M.
    Belperio, J. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [33] Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
    Jamie L. Todd
    Richard Vinisko
    Yi Liu
    Megan L. Neely
    Robert Overton
    Kevin R. Flaherty
    Imre Noth
    L. Kristin Newby
    Joseph A. Lasky
    Mitchell A. Olman
    Christian Hesslinger
    Thomas B. Leonard
    Scott M. Palmer
    John A. Belperio
    BMC Pulmonary Medicine, 20
  • [34] Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
    Todd, Jamie L.
    Vinisko, Richard
    Liu, Yi
    Neely, Megan L.
    Overton, Robert
    Flaherty, Kevin R.
    Noth, Imre
    Newby, L. Kristin
    Lasky, Joseph A.
    Olman, Mitchell A.
    Hesslinger, Christian
    Leonard, Thomas B.
    Palmer, Scott M.
    Belperio, John A.
    BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [35] Description Of Diagnostic Processes Undertaken For Patients With Idiopathic Pulmonary Fibrosis Enrolled In The Ipf-Pro Registry
    Holtze, C. H.
    Salisbury, M.
    Sheth, J. S.
    Belloli, E.
    White, E. S.
    Neely, M. L.
    Yow, E.
    Gamerman, V.
    Flaherty, K. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [36] HEALTH-RELATED QUALITY OF LIFE MEASURES IN IDIOPATHIC PULMONARY FIBROSIS: DATA FROM THE IPF-PRO REGISTRY
    Swaminathan, Aparna
    O'Brien, Emily
    Hellkamp, Anne
    Neely, Megan
    Bender, Shaun
    Snyder, Laurie
    Culver, Daniel
    Conoscenti, Craig
    Todd, Jamie
    Palmer, Scott
    Leonard, Thomas
    CHEST, 2019, 156 (04) : 180A - 181A
  • [37] Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
    Joao A. de Andrade
    Tejaswini Kulkarni
    Megan L. Neely
    Anne S. Hellkamp
    Amy Hajari Case
    Daniel A. Culver
    Kalpalatha Guntupalli
    Shaun Bender
    Craig S. Conoscenti
    Laurie D. Snyder
    Respiratory Research, 23
  • [38] Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
    de Andrade, Joao A.
    Kulkarni, Tejaswini
    Neely, Megan L.
    Hellkamp, Anne S.
    Case, Amy Hajari
    Culver, Daniel A.
    Guntupalli, Kalpalatha
    Bender, Shaun
    Conoscenti, Craig S.
    Snyder, Laurie D.
    RESPIRATORY RESEARCH, 2022, 23 (01)
  • [39] Rationale for and design of the Idiopathic Pulmonary Fibrosis-PRospective Outcomes (IPF-PRO) registry
    O'Brien, Emily C.
    Durheim, Michael T.
    Gamerman, Victoria
    Garfinkel, Sandy
    Anstrom, Kevin J.
    Palmer, Scott M.
    Conoscenti, Craig S.
    BMJ OPEN RESPIRATORY RESEARCH, 2016, 3 (01):
  • [40] Associations Between Circulating MicroRNAs and Clinical Outcomes in Patients with IPF: Data from the IPF-PRO Registry
    Luckhardt, T.
    Neely, M. L.
    Mulder, H.
    Belperio, J. A.
    Ramaswamy, M.
    Salisbury, M. L.
    Hesslinger, C.
    Palmer, S. M.
    Todd, J. L.
    Leonard, T. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
12345